Condition: Overweight · Obesity · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity or overweight, with or without type 2 diabetes, and on stable incretin background therapy. Participation in the study will last about 80 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Birmingham Clinical Research | Birmingham, Alabama, United States | Recruiting |
| RIO Clinical Trials - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Headlands Research - Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| Novak Clinical Research - Tucson - North La Cholla Boulevard | Tucson, Arizona, United States | Recruiting |
| Irvine Clinical Research | Irvine, California, United States | Recruiting |
| Scripps Whittier Diabetes Institute | La Jolla, California, United States | Recruiting |
| EndoTrials Center for Clinical Research | La Mesa, California, United States | Not Yet Recruiting |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | Recruiting |
| Care Access - Sacramento | Sacramento, California, United States | Recruiting |
| Artemis Institute for Clinical Research | San Diego, California, United States | Recruiting |
| Southern California Clinical Research | Santa Ana, California, United States | Recruiting |
| University Clinical Investigators, Inc. | Tustin, California, United States | Recruiting |
+ 161 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07392190